Enveric Biosciences Inc Ordinary Shares ENVB 深 沪
已收盘 12-05 16:00:00 美东时间
6.79
+0.680
+11.13%
华盛通- 最 高6.991
- 今 开5.99
- 成交量 11.44万股
- 最 低 5.6001
- 昨 收 6.11
- 总市值 351.93万
- 52周最高 96.30
- 市盈率 静 --
- 换手率 22.06%
- 52周最低 4.88
- 委 比 -93.59%
- 总股本 51.83万
- 历史最高 2700000.00
- 量 比 5.91
- 振 幅 22.76%
- 历史最低 5.6001
- 每 手 1
- 风险率 18.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enveric Biosciences Receives Notice of Allowance From U.S. Patent And Trademark Office For EVM401 Series Of Molecules For Mental Health Disorders Treatment
Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that
11-26 21:03
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock rose 10.2% to $2.8 during Wedn...
11-20 05:07
Enveric Biosciences GAAP EPS of -$10.81
Enveric Biosciences press release (ENVB): Q3 GAAP EPS of -$10.81. The net loss for the quarter included approximately $0.2 million in non-cash expenses related to stock-based compensation and other no...
11-15 05:49
Enveric Biosciences Plans Reverse Stock Split
The latest update is out from Enveric Biosciences ( ($ENVB) ). Enveric Bioscien...
10-24 05:05
Enveric Biosciences To Implement 1-For-12 Reverse Stock Split, Trading On Split-Adjusted Basis Starting October 28, 2025
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 28, 2025Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small
10-23 20:16
AbbVie ends in green six straight sessions of declines
AbbVie (NYSE:ABBV) snapped six consecutive sessions of losses on Thursday as the stock ended 0.29% lower at $226.87. Since October 8, the stock has closed in the red every day until October 15, during...
10-17 04:52
Enveric Biosciences Hires Fish And Richardson P.C. To Defend Its U.S. Patent With Claims Relevant To Bretisilocin
EB-003, Enveric's lead product candidate, is protected by a different patent family that includes an issued U.S. patent and pending U.S. and international patents, all of which are separate and distinct from the patent
10-15 20:09
Enveric Biosciences to explore digital asset treasury opportunities
Enveric Biosciences (NASDAQ:ENVB) on Tuesday said that its Board of Directors has authorized the Company’s Capital Markets Committee to explore and negotiate non-binding term sheets for potential Digi...
10-14 21:03
'Psychedelics Show Promise As An 'Entirely New Type Of Anti-Inflammatory Treatment,' Research Suggests' - Marijuana Moment
https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-suggests/
10-14 01:28
